Spensus Pharmaceuticals Private Limited, a active private limited company, was established on 24 February 2018 in Kadi, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999GJ2018PTC100978. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹5.20 Cr.
Employing 4 professional, Its leadership includes Nileshkumar Haribhai Patel (Director), Tanmay Natvarbhai Patel (Director). Past directors included Harilal Bhagvandas Patel, Kinjalben Nileshkumar Patel, Natvarlal Vitthalbhai Patel. It holds ₹17.98 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No.1,Survey No.284,B/H Honest Hotel, Dhanali Road,Ahmedabad-Mehsana Highway,G, Aneshpura,, Kadi, Gujarat, 382705.
U74999GJ2018PTC100978
100978
24 February 2018
₹6.00 Cr
₹5.20 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Spensus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nileshkumar Haribhai Patel | Director | 24 Feb 2018 | Current |
| Tanmay Natvarbhai Patel | Director | 24 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Sep 2020 | Past |
| Pramod Abcsdd | Director | 07 Sep 2020 | Past |
| Pramod Abcsdd | Director | 07 Sep 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Spensus Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 48995.35% increase. The company also saw a substantial fall in profitability, with a 15625.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 37.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2024, Spensus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹179,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Aug 2024 | Sidbi | ₹3.48 Cr | Open |
| 13 Jan 2022 | Sidbi | ₹9.00 Cr | Open |
| 13 Jan 2022 | Sidbi | ₹5.00 Cr | Open |
| 13 Jan 2022 | Sidbi | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Spensus Pharmaceuticals has a workforce of 4 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Spensus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spensus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Spensus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge with Sidbi amounted to Rs. 3.48 Cr with Charge ID 100973252 was registered on 27 Aug 2024. was completed.
The activity A charge with Sidbi of Rs. 5.00 Cr registered on 13 Jan 2022 with Charge ID 100533938 was modified on 27 Aug 2024. was completed.
Progress on Spensus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
A charge with Sidbi of Rs. 9.00 Cr registered on 13 Jan 2022 with Charge ID 100532879 was modified on 22 Feb 2022. was recorded as a recent event.
The activity A charge with Sidbi of Rs. 0.50 Cr registered on 13 Jan 2022 with Charge ID 100532868 was modified on 22 Feb 2022. was completed.
The CIN of Spensus Pharmaceuticals Private Limited is U74999GJ2018PTC100978.
Spensus Pharmaceuticals Private Limited is headquartered at Unit No.1,Survey No.284,B/H Honest Hotel, Dhanali Road,Ahmedabad-Mehsana Highway,G, Aneshpura,, Kadi, Gujarat, 382705.
Spensus Pharmaceuticals Private Limited was incorporated on 24 February 2018.
The current directors of Spensus Pharmaceuticals Private Limited are
The primary industry of Spensus Pharmaceuticals Private Limited is Manufacturing.
Spensus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Spensus Pharmaceuticals Private Limited is ₹6.00 Cr, and the paid-up capital is ₹5.20 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX